Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Phase III Study of ASP1941 - Open-label, Non-comparative Study to Assess the Long-term Safety, Tolerability and Efficacy of ASP1941 in Combination with an a-Glucosidase Inhibitor in Japanese Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control with an a-Glucosidase Inhibitor Alone
ipragliflozin
1941-CL-0108
NCT01242202
Diabetes Mellitus, Type 2
Phase 3
 
Formats available for datasets without specifications
January 2017

Powered by ideaPoint, Inc.